Arcadia Biosciences (RKDA) Misses Q2 EPS by 326c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($3.26). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reddit to join S&P 500 index on Aug. 18, shares leap
• Wolverine World Wide (WWW) PT Raised to $26 at Stifel as Multiple Can Move Higher